Pfizer Inc.
Pfizer
PFE · NYSE
Healthcare
Catalog as of September 15, 2026. Not a live market feed.
- Fiscal Year
- 2025
- Revenue
- $62.6B
- Assets
- $208.2B
- SEC filing
- DEF 14A
- Filed
- March 12, 2026
Executive Compensation
Compensation reported for Pfizer’s named executive officers, including salary, stock awards, incentive compensation, other compensation, and total compensation.
A. Bourla
Chairman And Chief Executive Officer
$27.6M
Reported total
- Salary
- $1,800,000
- Stock awards
- $9,442,705
- Incentives
- $5,400,000
- Option awards
- $8,998,141
- Other
- $1,944,455
C. Boshoff
Chief Scientific Officer And President, Research & Development
$10M
Reported total
- Salary
- $1,400,000
- Stock awards
- $1,808,655
- Incentives
- $3,150,000
- Option awards
- $2,999,378
- Other
- $648,006
D. Denton
Chief Financial Officer, EVP
$9.7M
Reported total
- Salary
- $1,388,964
- Stock awards
- $2,367,893
- Incentives
- $2,800,000
- Option awards
- $2,499,485
- Other
- $613,840
A. Malik
Chief U.S. Commercial Officer, EVP
$9.4M
Reported total
- Salary
- $1,386,817
- Stock awards
- $2,281,630
- Incentives
- $2,900,000
- Option awards
- $2,249,535
- Other
- $611,245
D. Lankler
Chief Legal Officer, EVP
$9.1M
Reported total
- Salary
- $1,411,787
- Stock awards
- $1,976,390
- Incentives
- $2,675,000
- Option awards
- $2,249,535
- Other
- $793,564
A. Bourla
Chairman And Chief Executive Officer
$27.6M
Reported total · FY2025 · SCT Total as filed
Source: DEF 14A Summary Compensation Table, filed March 12, 2026.
- Salary
- $1.8M
- Stock Awards
- $9.4M
- Option Awards
- $9M
- Incentives
- $5.4M
- Other
- $1.9M
Historical Compensation
A. Bourla total compensation, fiscal years 2023–2025.
| Fiscal Year | Salary | Stock Awards | Total Compensation |
|---|---|---|---|
| 2025 | $1,800,000 | $9,442,705 | $27,585,301 |
| 2024 | $1,800,000 | $4,838,694 | $24,648,727 |
| 2023 | $1,787,500 | $8,745,187 | $21,562,064 |
Named Executive Officers
A. Bourla
Chairman And Chief Executive Officer
Pfizer · PFE
$27.6M
FY 2025 · DEF 14A
D. Denton
Chief Financial Officer, EVP
Pfizer · PFE
$9.7M
FY 2025 · DEF 14A
C. Boshoff
Chief Scientific Officer And President, Research & Development
Pfizer · PFE
$10M
FY 2025 · DEF 14A
A. Malik
Chief U.S. Commercial Officer, EVP
Pfizer · PFE
$9.4M
FY 2025 · DEF 14A
D. Lankler
Chief Legal Officer, EVP
Pfizer · PFE
$9.1M
FY 2025 · DEF 14A
Source information
- Company
- Pfizer Inc.
- Ticker
- PFE · NYSE
- Filing type
- DEF 14A
- Fiscal year
- 2025
- Filing date
- March 12, 2026
- SEC accession number
- 0000078003-26-000033
Source: U.S. Securities and Exchange Commission, DEF 14A Summary Compensation Table. View SEC filing
Related Companies
Johnson & Johnson
JNJ · NYSE
Joaquin Duato
Chairman/CEO
$32.8M
FY 2025 reported total
View company →
UnitedHealth
UnitedHealth Group Incorporated
UNH · NYSE
Stephen Hemsley
Chief Executive Officer
$60.9M
FY 2025 reported total
View company →
AbbVie
AbbVie Inc.
ABBV · NYSE
Robert A. Michael
Chairman Of The Board And Chief Executive Officer
$32.5M
FY 2025 reported total
View company →
Abbott
Abbott Laboratories
ABT · NYSE
Robert B. Ford
Chairman Of The Board And Chief Executive Officer
$24.2M
FY 2025 reported total
View company →